Literature DB >> 11446343

DNA methylation in breast cancer.

X Yang1, L Yan, N E Davidson.   

Abstract

Like all cancers, breast cancer is considered to result in part from the accumulation of multiple genetic alterations leading to oncogene overexpression and tumor suppressor loss. More recently, the role of epigenetic change as a distinct and crucial mechanism to silence a variety of methylated tissue-specific and imprinted genes has emerged in many cancer types. This review will briefly discuss basic aspects of DNA methylation, recent advances in DNA methyltransferases, the role of altered chromatin organization and the concept of gene transcriptional regulation built on methylated CpGs. In particular, we discuss epigenetic regulation of certain critical tumor suppressor and growth regulatory genes implicated in breast cancer, and its relevance to breast cancer diagnosis, prognosis, progression and therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11446343     DOI: 10.1677/erc.0.0080115

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  69 in total

Review 1.  Prognostic factors in breast cancer: current and new predictors of metastasis.

Authors:  D F Hayes; C Isaacs; V Stearns
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

Review 2.  Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.

Authors:  Ashley G Rivenbark; Siobhan M O'Connor; William B Coleman
Journal:  Am J Pathol       Date:  2013-08-27       Impact factor: 4.307

3.  [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].

Authors:  E Noetzel; J Veeck; F Horn; A Hartmann; R Knüchel; E Dahl
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

4.  Decreased DNA Methylations at the Progesterone Receptor Promoter A Induce Functional Progesterone Withdrawal in Human Parturition.

Authors:  Xia Li; Cheng Chen; Hui Luo; Jennifer C van Velkinburgh; Bing Ni; Qing Chang
Journal:  Reprod Sci       Date:  2014-01-08       Impact factor: 3.060

5.  Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women.

Authors:  Wenyi Qin; Weizhu Zhu; Huidong Shi; John E Hewett; Rachel L Ruhlen; Ruth S MacDonald; George E Rottinghaus; Yin-Chieh Chen; Edward R Sauter
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

6.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.

Authors:  Brandon J Metge; Andra R Frost; Judy A King; Donna Lynn Dyess; Danny R Welch; Rajeev S Samant; Lalita A Shevde
Journal:  Clin Exp Metastasis       Date:  2008-06-20       Impact factor: 5.150

7.  Promoter Hypermethylation in Tumor Suppressing Genes p16 and FHIT and Their Relationship with Estrogen Receptor and Progesterone Receptor Status in Breast Cancer Patients from Northern India.

Authors:  Mohammad Raish; Varinderpal S Dhillon; Arif Ahmad; Mushtaq Ahmad Ansari; Shahid Mudassar; Mohammad Shahid; Vineeta Batra; Pawan Gupta; Bhudev Chandra Das; Nk Shukla; Syed Akhtar Husain
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

8.  Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.

Authors:  Wei Zhou; Zheng Jiang; Ningbo Liu; Fenghua Xu; Peie Wen; Yanbing Liu; Weixia Zhong; Xianrang Song; Xiaotian Chang; Xiuli Zhang; Guangsheng Wei; Jinming Yu
Journal:  J Cancer Res Clin Oncol       Date:  2008-08-01       Impact factor: 4.553

9.  ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.

Authors:  Gerusa G Seniski; Anamaria A Camargo; Daniela F Ierardi; Edneia A S Ramos; Mariana Grochoski; Enilze S F Ribeiro; Iglenir J Cavalli; Fabio O Pedrosa; Emanuel M de Souza; Silvio M Zanata; Fabrício F Costa; Giseli Klassen
Journal:  BMC Cancer       Date:  2009-03-06       Impact factor: 4.430

10.  Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.

Authors:  Stella Tommasi; Deborah L Karm; Xiwei Wu; Yun Yen; Gerd P Pfeifer
Journal:  Breast Cancer Res       Date:  2009-02-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.